Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

HBI 2022: Resilient fertility a “ridiculously positive market”

Resilient, recession-proof fertility has a strong future ahead, but will face some challenges in the coming months according to an HBI 2022 panel. Demand is strong, patients came back quickly when clinics - and borders - reopened, and the threat of recession is not causing anyone to lose sleep. 

HBI 2022: Panel sees a rosy future for ophthalmology

Ophthalmology continues to be a big area of investor interest, with considerable scope for consolidation in both healthcare services and also medical devices. As governments in the UK, Finland and parts of Eastern Europe in particular continue to increase outsourcing, the potential to unlock additional private pay services is increasing, and upselling of more complex lenses is on the rise. An expert panel convened at HBI 2022 to discuss the opportunities and challenges in the post-pandemic landscape.

FREE BLOG NHS bad, Bismarck good

There was profound pessimism about Westminster-style NHS healthcare systems on display at the European Healthcare Policy Group (EHPG). And even more pessimism about integrated healthcare, the latest buzzword from NHS England.

Why Westminster NHS systems fail

Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.

Twenty things we learned at HBI 2022

HBI 2022, the year's largest CxO-level for-profit healthcare services conference, took place in central London this week. The conference stages and the floor were awash with interesting ideas, staggering statistics, suggestions for building a better business and the buzz of new friendships being formed. As always, there were new things to learn. Here are twenty of our top take aways from this year's event.

HBI 2022: Lack of debt may hit M&A in second half

M&A deals in health care services such as the bid for British health and beauty retailer and pharmacy chain Boots are coming under threat as market uncertainty, interest rates and inflation soar. Massive deals may fail if debt dries up. This could lead to a further slow-down in M&A activity in the second half of 2022, following a record year 2021.

Find Us